Applications of coronary intervention in the management of ischemic left ventricular dysfunction

被引：0
|
作者：
Vetrovec, G [1 ]
Lipinski, M [1 ]
机构：
[1] Virginia Commonwealth Univ, Med Coll Virginia Hosp, Richmond, VA 23284 USA
来源：
ADVANCES IN HEART FAILURE | 2002年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In summary PCI has shown progressive improvement in outcome. The impact of these results, coupled with improved adjuctive medical therapy, make PCI a more competitive and attractive treatment for patients with multi-vessel disease and reduced (ideally viable) left ventricular function Aggressive strategies in this patient population are associated with improved outcomes.
引用
收藏
页码：183 / 186
页数：4
相关论文
共 50 条
  • [41] Prevalence of viable and ischemic myocardium in patients with chronic coronary artery disease and left ventricular dysfunction
    Kitsiou, A. N.
    Karas, S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2009, 11 (0B) : S11 - S12
  • [42] Treating ischemic left ventricular dysfunction with hypertonic saline administered after coronary occlusion in pigs
    Sidi, Avner
    Muehlschlegel, Jochen D.
    Kirby, David S.
    Kirby, Robert R.
    Lobato, Emilio B.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2007, 21 (03) : 400 - 405
  • [43] Trimetazidine improves myocardial perfusion and left ventricular function in ischemic left ventricular dysfunction
    Feola, M
    Biggi, A
    Francini, A
    Leonardi, G
    Ribichini, F
    Ferrero, V
    Uslenghi, E
    CLINICAL NUCLEAR MEDICINE, 2004, 29 (02) : 117 - 118
  • [44] NEUROHORMONES IN PATIENTS WITH ISCHEMIC LEFT-VENTRICULAR DYSFUNCTION
    POULEUR, H
    BENEDICT, CR
    ROUSSEAU, MF
    CARDIOVASCULAR DRUGS AND THERAPY, 1994, 8 : 313 - 317
  • [45] Asymptomatic ischemic left ventricular dysfunction: myocardial remodeling
    Pangonyte, Dalia
    Stalioraityte, Elena
    Kazlauskaite, Danute
    Ziuraitiene, Reda
    Palubinskiene, Jolita
    Utkiene, Lina
    CARDIOLOGY, 2009, 113 : 92 - 92
  • [46] ISCHEMIC LEFT-VENTRICULAR DYSFUNCTION - FRUSEMIDE OR NITRATE
    TWEDDEL, A
    MARTIN, W
    MCGHIE, I
    HUTTON, I
    BRITISH HEART JOURNAL, 1988, 59 (01): : 139 - 140
  • [47] Association of revascularization with mortality in ischemic left ventricular dysfunction
    Tao, M.
    Liu, Y.
    Radakrishnan, A.
    Al-Sadawi, M.
    Masson, R.
    Rahman, T.
    Mann, N.
    Pyo, R.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [48] ICD implantation in patients with ischemic left ventricular dysfunction
    Patel J.B.
    Koplan B.A.
    Current Treatment Options in Cardiovascular Medicine, 2009, 11 (1) : 3 - 9
  • [49] Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
    Bonow, Robert O.
    Maurer, Gerald
    Lee, Kerry L.
    Holly, Thomas A.
    Binkley, Philip F.
    Desvigne-Nickens, Patrice
    Drozdz, Jaroslaw
    Farsky, Pedro S.
    Feldman, Arthur M.
    Doenst, Torsten
    Michler, Robert E.
    Berman, Daniel S.
    Nicolau, Jose C.
    Pellikka, Patricia A.
    Wrobel, Krzysztof
    Alotti, Nasri
    Asch, Federico M.
    Favaloro, Liliana E.
    She, Lilin
    Velazquez, Eric J.
    Jones, Robert H.
    Panza, Julio A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (17): : 1617 - 1625
  • [50] NISOLDIPINE IN SEVERE ISCHEMIC LEFT-VENTRICULAR DYSFUNCTION
    POULEUR, H
    ROUSSEAU, MF
    EUROPEAN HEART JOURNAL, 1993, 14 : 45 - 47
12345